Literature DB >> 24491966

Contributions of signaling by dopamine neurons in dorsal striatum to cognitive behaviors corresponding to those observed in Parkinson's disease.

Martin Darvas1, Charles W Henschen2, Richard D Palmiter3.   

Abstract

Although the cardinal features of Parkinson's disease (PD) are motor symptoms, PD also causes cognitive deficits including cognitive flexibility and working memory, which are strongly associated with prefrontal cortex (PFC) functions. Yet, early stage PD is not characterized by pathology in the PFC but by a loss of dopaminergic (DA) projections from the substantia nigra to the dorsal striatum. Moreover, the degree to which PD symptoms can be ascribed to the loss of DA alone or to the loss of DA neurons is unknown. We addressed these issues by comparing mouse models of either chronic DA depletion or loss of DA projections to the dorsal striatum. We achieved equal levels of striatal DA reduction in both models which ranged from mild (~25%) to moderate (~60%). Both models displayed DA concentration-dependent reductions of motor function as well as mild deficits of cognitive flexibility and working memory. Interestingly, whereas both motor function and cognitive flexibility were more severely impaired after mild ablation of DA neurons as compared to mild loss of DA alone, both models had equal deficits after moderate loss of DA. Our results confirm contributions of nigro-striatal dopamine signaling to cognitive behaviors that are affected in early stage PD. Furthermore, our findings suggest that the phenotype after ablation of DA neurons accrues from factors beyond the mere loss of DA. Published by Elsevier Inc.

Entities:  

Keywords:  6-Hydroxydopamine; Dopamine-deficient mice; Executive function; Neurodegeneration; Tyrosine hydroxylase; Viral inactivation

Mesh:

Substances:

Year:  2014        PMID: 24491966      PMCID: PMC4001780          DOI: 10.1016/j.nbd.2014.01.017

Source DB:  PubMed          Journal:  Neurobiol Dis        ISSN: 0969-9961            Impact factor:   5.996


  65 in total

Review 1.  Lewy pathology and neurodegeneration in premotor Parkinson's disease.

Authors:  Kelly Del Tredici; Heiko Braak
Journal:  Mov Disord       Date:  2012-04-15       Impact factor: 10.338

2.  Contributions of striatal dopamine signaling to the modulation of cognitive flexibility.

Authors:  Martin Darvas; Richard D Palmiter
Journal:  Biol Psychiatry       Date:  2010-11-11       Impact factor: 13.382

3.  Selective inactivation of adenosine A(2A) receptors in striatal neurons enhances working memory and reversal learning.

Authors:  Catherine J Wei; Philipp Singer; Joana Coelho; Detlev Boison; Joram Feldon; Benjamin K Yee; Jiang-Fan Chen
Journal:  Learn Mem       Date:  2011-06-21       Impact factor: 2.460

4.  Nigrostriatal overabundance of α-synuclein leads to decreased vesicle density and deficits in dopamine release that correlate with reduced motor activity.

Authors:  Meret Nora Gaugler; Ozgur Genc; Wojciech Bobela; Safa Mohanna; Mustafa Taleb Ardah; Omar Mukhtar El-Agnaf; Marco Cantoni; Jean-Charles Bensadoun; Ralf Schneggenburger; Graham W Knott; Patrick Aebischer; Bernard Laurent Schneider
Journal:  Acta Neuropathol       Date:  2012-02-24       Impact factor: 17.088

Review 5.  A possible role for the striatum in the pathogenesis of the cognitive symptoms of schizophrenia.

Authors:  Eleanor H Simpson; Christoph Kellendonk; Eric Kandel
Journal:  Neuron       Date:  2010-03-11       Impact factor: 17.173

Review 6.  Dopamine receptor agonists for the treatment of early or advanced Parkinson's disease.

Authors:  Santiago Perez-Lloret; Olivier Rascol
Journal:  CNS Drugs       Date:  2010-11       Impact factor: 5.749

7.  Retinal dopamine mediates multiple dimensions of light-adapted vision.

Authors:  Chad R Jackson; Guo-Xiang Ruan; Fazila Aseem; Jane Abey; Karen Gamble; Greg Stanwood; Richard D Palmiter; P Michael Iuvone; Douglas G McMahon
Journal:  J Neurosci       Date:  2012-07-04       Impact factor: 6.167

8.  Clinical progression in Parkinson disease and the neurobiology of axons.

Authors:  Hsiao-Chun Cheng; Christina M Ulane; Robert E Burke
Journal:  Ann Neurol       Date:  2010-06       Impact factor: 10.422

Review 9.  Priorities in Parkinson's disease research.

Authors:  Wassilios G Meissner; Mark Frasier; Thomas Gasser; Christopher G Goetz; Andres Lozano; Paola Piccini; José A Obeso; Olivier Rascol; Anthony Schapira; Valerie Voon; David M Weiner; François Tison; Erwan Bezard
Journal:  Nat Rev Drug Discov       Date:  2011-05       Impact factor: 84.694

10.  Restricting dopaminergic signaling to either dorsolateral or medial striatum facilitates cognition.

Authors:  Martin Darvas; Richard D Palmiter
Journal:  J Neurosci       Date:  2010-01-20       Impact factor: 6.167

View more
  21 in total

1.  Dopamine Deficiency Reduces Striatal Cholinergic Interneuron Function in Models of Parkinson's Disease.

Authors:  Jonathan W McKinley; Ziqing Shi; Ivana Kawikova; Matthew Hur; Ian J Bamford; Suma Priya Sudarsana Devi; Annie Vahedipour; Martin Darvas; Nigel S Bamford
Journal:  Neuron       Date:  2019-07-16       Impact factor: 17.173

2.  Synergy of Distinct Dopamine Projection Populations in Behavioral Reinforcement.

Authors:  Gabriel Heymann; Yong S Jo; Kathryn L Reichard; Naomi McFarland; Charles Chavkin; Richard D Palmiter; Marta E Soden; Larry S Zweifel
Journal:  Neuron       Date:  2019-12-23       Impact factor: 17.173

3.  Relative contributions of severe dopaminergic neuron ablation and dopamine depletion to cognitive impairment.

Authors:  R Garrett Morgan; Jeffrey T Gibbs; Erica J Melief; Nadia O Postupna; Emily E Sherfield; Angela Wilson; C Dirk Keene; Thomas J Montine; Richard D Palmiter; Martin Darvas
Journal:  Exp Neurol       Date:  2015-06-14       Impact factor: 5.330

4.  Atlas of the Striatum and Globus Pallidus in the Tree Shrew: Comparison with Rat and Mouse.

Authors:  Rong-Jun Ni; Zhao-Huan Huang; Yu-Mian Shu; Yu Wang; Tao Li; Jiang-Ning Zhou
Journal:  Neurosci Bull       Date:  2018-03-05       Impact factor: 5.203

5.  Impact of partial dopamine depletion on cognitive flexibility in BDNF heterozygous mice.

Authors:  Vinay Parikh; Sean X Naughton; Brittney Yegla; Dawn M Guzman
Journal:  Psychopharmacology (Berl)       Date:  2016-02-10       Impact factor: 4.530

6.  Partial lesion of the nigrostriatal dopamine pathway in rats impairs egocentric learning but not spatial learning or behavioral flexibility.

Authors:  Katharine M Seip-Cammack; James J Young; Megan E Young; Matthew L Shapiro
Journal:  Behav Neurosci       Date:  2017-02-20       Impact factor: 1.912

7.  Executive function deficits and glutamatergic protein alterations in a progressive 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson's disease.

Authors:  Lacey Pflibsen; Katherine A Stang; Michelle D Sconce; Vanessa B Wilson; Rebecca L Hood; Charles K Meshul; Suzanne H Mitchell
Journal:  J Neurosci Res       Date:  2015-08-31       Impact factor: 4.164

8.  Cognitive and motor deficits in older adults with HIV infection: Comparison with normal ageing and Parkinson's disease.

Authors:  Eva M Müller-Oehring; Rosemary Fama; Taylor F Levine; Cheshire Hardcastle; Ryan Goodcase; Talora Martin; Varsha Prabhakar; Helen M Brontë-Stewart; Kathleen L Poston; Edith V Sullivan; Tilman Schulte
Journal:  J Neuropsychol       Date:  2020-10-08       Impact factor: 2.864

9.  Characterization of cognitive impairments and neurotransmitter changes in a novel transgenic mouse lacking Slc10a4.

Authors:  E J Melief; J T Gibbs; X Li; R G Morgan; C D Keene; T J Montine; R D Palmiter; M Darvas
Journal:  Neuroscience       Date:  2016-03-19       Impact factor: 3.590

Review 10.  Preclinical Evidence for a Role of the Nicotinic Cholinergic System in Parkinson's Disease.

Authors:  Xiomara A Perez
Journal:  Neuropsychol Rev       Date:  2015-11-09       Impact factor: 7.444

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.